# MARRIOTT VACATIONS WORLDWIDE Corp: financial statements, quarterly

VAC · NYSE · CIK 1524358 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vac.md) · [Financials](/companies/vac/financials.md) · [Filings](/companies/vac/filings.md) · [Insiders](/companies/vac/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vac/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,105](/filings/0001524358-24-000109.md) | [1,111 d](/filings/0001524358-26-000010.md) | [1,112](/filings/0001524358-25-000098.md) | [1,055](/filings/0001524358-25-000152.md) | [1,218](/filings/0001524358-25-000166.md) | [1,240 d](/filings/0001524358-26-000010.md) | [1,112](/filings/0001524358-26-000022.md) | [1,156](/filings/0001524358-26-000037.md) | [1,173](/filings/0001524358-25-000166.md) | [1,231 d](/filings/0001524358-26-000010.md) | [1,165](/filings/0001524358-26-000022.md) | [1,228](/filings/0001524358-26-000037.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [24.0](/filings/0001524358-24-000109.md) | [31.0 d](/filings/0001524358-26-000010.md) | [35.0](/filings/0001524358-25-000098.md) | [10.0](/filings/0001524358-25-000152.md) | [34.0](/filings/0001524358-25-000166.md) | [10.0 d](/filings/0001524358-26-000010.md) | [45.0](/filings/0001524358-26-000022.md) | [25.0](/filings/0001524358-26-000037.md) | [3.0](/filings/0001524358-25-000166.md) | [(65.0) d](/filings/0001524358-26-000010.md) | [23.0](/filings/0001524358-26-000022.md) | [37.0](/filings/0001524358-26-000037.md) |
| Net income | $m | [42.0](/filings/0001524358-24-000109.md) | [35.0 d](/filings/0001524358-26-000010.md) | [47.0](/filings/0001524358-25-000098.md) | [37.0](/filings/0001524358-25-000152.md) | [84.0](/filings/0001524358-25-000166.md) | [50.0 d](/filings/0001524358-26-000010.md) | [56.0](/filings/0001524358-26-000022.md) | [69.0](/filings/0001524358-26-000037.md) | [(2.0)](/filings/0001524358-25-000166.md) | [(431) d](/filings/0001524358-26-000010.md) | [22.0](/filings/0001524358-26-000022.md) | [77.0](/filings/0001524358-26-000037.md) |
| Diluted EPS | $ per share | [1.09](/filings/0001524358-24-000109.md) | not reported | [1.22](/filings/0001524358-25-000098.md) | [0.98](/filings/0001524358-25-000152.md) | [2.12](/filings/0001524358-25-000166.md) | not reported | [1.46](/filings/0001524358-26-000022.md) | [1.77](/filings/0001524358-26-000037.md) | [(0.07)](/filings/0001524358-25-000166.md) | not reported | [0.64](/filings/0001524358-26-000022.md) | [2.12](/filings/0001524358-26-000037.md) |
| Basic EPS | $ per share | [1.16](/filings/0001524358-24-000109.md) | not reported | [1.32](/filings/0001524358-25-000098.md) | [1.04](/filings/0001524358-25-000152.md) | [2.38](/filings/0001524358-25-000166.md) | not reported | [1.60](/filings/0001524358-26-000022.md) | [1.98](/filings/0001524358-26-000037.md) | [(0.07)](/filings/0001524358-25-000166.md) | not reported | [0.64](/filings/0001524358-26-000022.md) | [2.21](/filings/0001524358-26-000037.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001524358-23-000039.md) | [0.2](/filings/0001524358-25-000044.md) | [0.2](/filings/0001524358-24-000039.md) | [0.2](/filings/0001524358-24-000076.md) | [0.2](/filings/0001524358-24-000109.md) | [0.2](/filings/0001524358-26-000010.md) | [0.2](/filings/0001524358-25-000098.md) | [0.2](/filings/0001524358-25-000152.md) | [0.5](/filings/0001524358-25-000166.md) | [0.4](/filings/0001524358-26-000037.md) | [0.3](/filings/0001524358-26-000022.md) | [0.2](/filings/0001524358-26-000037.md) |
| Total assets | $bn | [9.5](/filings/0001524358-23-000039.md) | [9.7](/filings/0001524358-25-000044.md) | [9.9](/filings/0001524358-24-000039.md) | [9.6](/filings/0001524358-24-000076.md) | [9.7](/filings/0001524358-24-000109.md) | [9.8](/filings/0001524358-26-000010.md) | [9.9](/filings/0001524358-25-000098.md) | [9.9](/filings/0001524358-25-000152.md) | [10.1](/filings/0001524358-25-000166.md) | [9.8](/filings/0001524358-26-000037.md) | [9.6](/filings/0001524358-26-000022.md) | [9.5](/filings/0001524358-26-000037.md) |
| Total liabilities | $bn | [7.0](/filings/0001524358-23-000039.md) | [7.3](/filings/0001524358-25-000044.md) | [7.5](/filings/0001524358-24-000039.md) | [7.2](/filings/0001524358-24-000076.md) | [7.3](/filings/0001524358-24-000109.md) | [7.4](/filings/0001524358-26-000010.md) | [7.4](/filings/0001524358-25-000098.md) | [7.4](/filings/0001524358-25-000152.md) | [7.7](/filings/0001524358-25-000166.md) | [7.8](/filings/0001524358-26-000037.md) | [7.6](/filings/0001524358-26-000022.md) | [7.4](/filings/0001524358-26-000037.md) |
| Shareholders' equity | $bn | [2.4](/filings/0001524358-23-000039.md) | [2.4](/filings/0001524358-25-000044.md) | [2.4](/filings/0001524358-24-000039.md) | [2.4](/filings/0001524358-24-000076.md) | [2.4](/filings/0001524358-24-000109.md) | [2.4](/filings/0001524358-26-000010.md) | [2.4](/filings/0001524358-25-000098.md) | [2.5](/filings/0001524358-25-000152.md) | [2.5](/filings/0001524358-25-000166.md) | [2.0](/filings/0001524358-26-000037.md) | [2.0](/filings/0001524358-26-000022.md) | [2.1](/filings/0001524358-26-000037.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [122 d](/filings/0001524358-24-000109.md) | [83.0 d](/filings/0001524358-26-000010.md) | [3.0](/filings/0001524358-25-000098.md) | [30.0 d](/filings/0001524358-25-000152.md) | [72.0 d](/filings/0001524358-25-000166.md) | [100 d](/filings/0001524358-26-000010.md) | [8.0](/filings/0001524358-26-000022.md) | [(48.0) d](/filings/0001524358-26-000037.md) | [62.0 d](/filings/0001524358-25-000166.md) | [6.0 d](/filings/0001524358-26-000010.md) | [(4.0)](/filings/0001524358-26-000022.md) | [80.0 d](/filings/0001524358-26-000037.md) |
| Capital expenditure | $m | [29.0 d](/filings/0001524358-24-000109.md) | [26.0 d](/filings/0001524358-26-000010.md) | [16.0](/filings/0001524358-25-000098.md) | [13.0 d](/filings/0001524358-25-000152.md) | [14.0 d](/filings/0001524358-25-000166.md) | [14.0 d](/filings/0001524358-26-000010.md) | [14.0](/filings/0001524358-26-000022.md) | [20.0 d](/filings/0001524358-26-000037.md) | [11.0 d](/filings/0001524358-25-000166.md) | [12.0 d](/filings/0001524358-26-000010.md) | [8.0](/filings/0001524358-26-000022.md) | [14.0 d](/filings/0001524358-26-000037.md) |
| Dividends paid | $m | [0.0 d](/filings/0001524358-24-000109.md) | [26.0 d](/filings/0001524358-26-000010.md) | [54.0](/filings/0001524358-25-000098.md) | [27.0 d](/filings/0001524358-25-000152.md) | [0.0 d](/filings/0001524358-25-000166.md) | [26.0 d](/filings/0001524358-26-000010.md) | [55.0](/filings/0001524358-26-000022.md) | [28.0 d](/filings/0001524358-26-000037.md) | [(56.0) d](/filings/0001524358-25-000166.md) | [83.0 d](/filings/0001524358-26-000010.md) | [55.0](/filings/0001524358-26-000022.md) | [27.0 d](/filings/0001524358-26-000037.md) |
| Share repurchases | $m | [86.0 d](/filings/0001524358-24-000109.md) | [38.0 d](/filings/0001524358-26-000010.md) | [24.0](/filings/0001524358-25-000098.md) | [12.0 d](/filings/0001524358-25-000152.md) | [9.0 d](/filings/0001524358-25-000166.md) | [11.0 d](/filings/0001524358-26-000010.md) | [36.0](/filings/0001524358-26-000022.md) | [0.0 d](/filings/0001524358-26-000037.md) | [0.0 d](/filings/0001524358-25-000166.md) | [25.0 d](/filings/0001524358-26-000010.md) | [0.0](/filings/0001524358-26-000022.md) | [0.0 d](/filings/0001524358-26-000037.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [43.4](/filings/0001524358-23-000039.md) | [44.4](/filings/0001524358-24-000039.md) | [43.8](/filings/0001524358-24-000076.md) | [43.3](/filings/0001524358-24-000109.md) | [42.2](/filings/0001524358-25-000098.md) | [42.2](/filings/0001524358-25-000152.md) | [42.1](/filings/0001524358-25-000166.md) | [42.0](/filings/0001524358-26-000022.md) | [41.7](/filings/0001524358-26-000037.md) | [34.9](/filings/0001524358-25-000166.md) | [34.8](/filings/0001524358-26-000022.md) | [38.2](/filings/0001524358-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 34,395,320 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001524358-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.